BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35381275)

  • 21. A systematic review of intraluminal high dose rate brachytherapy in the management of malignant biliary tract obstruction and cholangiocarcinoma.
    Taggar AS; Mann P; Folkert MR; Aliakbari S; Myrehaug SD; Dawson LA
    Radiother Oncol; 2021 Dec; 165():60-74. PubMed ID: 34695521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of brachytherapy in the treatment of cancers of the anal canal. Long-term follow-up and multivariate analysis of a large monocentric retrospective series.
    Lestrade L; De Bari B; Pommier P; Montbarbon X; Lavergne E; Ardiet JM; Carrie C
    Strahlenther Onkol; 2014 Jun; 190(6):546-54. PubMed ID: 24615188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicity and clinical outcomes of single-fraction high-dose-rate brachytherapy combined with external beam radiotherapy for high-/very high-risk prostate cancer: A dosimetric analysis of toxicity.
    Sakurai T; Takamatsu S; Shibata S; Iwata K; Taka M; Gabata T; Kumano T; Makino T; Mizokami A
    Jpn J Radiol; 2020 Dec; 38(12):1197-1208. PubMed ID: 32737768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interstitial hyperthermia and high dose rate brachytherapy in the treatment of anal cancer: a phase I/II study.
    Kapp KS; Kapp DS; Stuecklschweiger G; Berger A; Geyer E
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):189-99. PubMed ID: 8270441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive factors for early and late local toxicities in anal cancer treated by radiotherapy in combination with or without chemotherapy.
    Doyen J; Benezery K; Follana P; Ortholan C; Gérard JP; Hannoun-Levi JM; Gal J; Francois E
    Dis Colon Rectum; 2013 Oct; 56(10):1125-33. PubMed ID: 24022529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy.
    Yamada Y; Kollmeier MA; Pei X; Kan CC; Cohen GN; Donat SM; Cox BW; Zelefsky MJ
    Brachytherapy; 2014; 13(2):111-6. PubMed ID: 24373762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
    Liu R; Wang X; Tian JH; Yang K; Wang J; Jiang L; Hao XY
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD007563. PubMed ID: 25300170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer.
    Saarilahti K; Arponen P; Vaalavirta L; Tenhunen M
    Radiother Oncol; 2008 Jun; 87(3):383-90. PubMed ID: 18501454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interstitial pulsed-dose-rate brachytherapy for the treatment of squamous cell anal carcinoma: A retrospective single institution analysis.
    Boukhelif W; Ferri-Molina M; Mazeron R; Maroun P; Duhamel-Oberlander AS; Dumas I; Martinetti F; Guemnie-Tafo A; Chargari C; Haie-Meder C
    Brachytherapy; 2015; 14(4):549-53. PubMed ID: 25935731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensity modulated radiotherapy in anal canal squamous cell carcinoma: Implementation and outcomes.
    Das A; Arunsingh M; Bhattacharyya T; Prasath SS; Balakrishnan A; Mallick I
    J Cancer Res Ther; 2021; 17(4):975-981. PubMed ID: 34528551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.
    Martinez AA; Kestin LL; Stromberg JS; Gonzalez JA; Wallace M; Gustafson GS; Edmundson GK; Spencer W; Vicini FA
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):343-52. PubMed ID: 10802358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interstitial brachytherapy as a boost to patients with anal carcinoma and poor response to chemoradiation: Single-institution long-term results.
    Gryc T; Ott O; Putz F; Knippen S; Raptis D; Fietkau R; Strnad V
    Brachytherapy; 2016; 15(6):865-872. PubMed ID: 27720203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twenty-year experience in the management of squamous cell anal canal carcinoma with interstitial brachytherapy.
    López Guerra JL; Lozano AJ; Pera J; Gutiérrez C; Cambray M; Ferrer F; Guedea F
    Clin Transl Oncol; 2011 Jul; 13(7):472-9. PubMed ID: 21775274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerance of high-dose-rate brachytherapy boost after external radiotherapy in the treatment of squamous cell carcinoma of the anal canal.
    Bertin E; Benezery K; Kee DLC; François E; Evesque L; Gautier M; Gerard JP; Hannoun-Levi JM; Falk AT
    J Contemp Brachytherapy; 2018 Dec; 10(6):522-531. PubMed ID: 30662475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. External beam radiotherapy plus brachytherapy boost in treatment of anal canal carcinoma.
    Stojanović S; Radosević-Jelić I; Dabić-Stanković K; Popov I; Josifovski J
    Acta Chir Iugosl; 2007; 54(3):33-8. PubMed ID: 17988027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colorectal complications of external beam radiation versus brachytherapy for prostate cancer.
    Lesperance RN; Kjorstadt RJ; Halligan JB; Steele SR
    Am J Surg; 2008 May; 195(5):616-20; discussion 620. PubMed ID: 18374892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
    Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High dose rate cobalt-60 afterloading intracavitary therapy of uterine cervical carcinomas in Srinagarind hospital - analysis of complications.
    Pesee M; Krusun S; Padoongcharoen P
    Asian Pac J Cancer Prev; 2010; 11(2):491-4. PubMed ID: 20843138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients.
    Touboul E; Schlienger M; Buffat L; Lefkopoulos D; Pène F; Parc R; Tiret E; Gallot D; Malafosse M; Laugier A
    Cancer; 1994 Mar; 73(6):1569-79. PubMed ID: 8156483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.